Moderna, Inc.

576 articles with Moderna, Inc.

• Moderna Announces Transition To A Clinical Stage Company, Provides Business Update And Outlines 2016 Strategic Priorities

  1/12/2016

• Booming Moderna Eyes Six Human Trials in 2016, Inks Deals with AstraZeneca PLC, Merck & Co. and Signed Huge Lease in Cambridge for R&D Growth

  1/12/2016

• Moderna Licenses New Vaccine Candidates Against A New Viral Target To Merck & Co.

  1/11/2016

• AstraZeneca PLC And Moderna Announce New Collaboration To Co-Develop And Co-Commercialize Immuno-Oncology mRNA Therapeutics

  1/11/2016

• Moderna And PPD Announce Strategic Collaboration To Support Clinical Development Of Novel mRNATherapeutics

  1/8/2016

• Moderna To Present At 2016 J.P. Morgan Healthcare Conference

  1/4/2016

• Dr. Elizabeth Nabel Joins Moderna’s Board Of Directors

  12/15/2015

• Engineered mRNA Company Moderna Launches 4th Spinoff, Caperna

  10/22/2015

• Moderna Debuts Third mRNA Startup Elpidera, Will Continuing Hiring Plan

  5/13/2015

• Moderna #1 On CNBC Disruptor 50 List

  5/12/2015

• Moderna Therapeutics, Inc. Appoints Tal Zaks, Former Head Of Sanofi Global Oncology, As Chief Medical Officer

  3/16/2015

• Moderna Therapeutics, Inc. And Institut Pasteur Sign Strategic Research Collaboration

  2/3/2015

• Merck & Co. Jumps Into RNA Frenzy With $100 Million Bet on Moderna Therapeutics, Inc.

  1/14/2015

• Moderna Therapeutics, Inc. Launches New Venture Valera LLC For Infectious Diseases

  1/8/2015

• Massachusetts Biotech Moderna Therapeutics, Inc. Raises Record $450 Million; Will Hire 100 New Staffers

  1/7/2015

• Moderna Therapeutics, Inc. To Present At 33rd Annual J.P. Morgan Healthcare Conference

  1/6/2015

• Moderna Therapeutics, Inc. To Collaborate With Karolinska Institute And Karolinska University Hospital On Discovery Of New Messenger RNA Therapeutics™

  10/16/2014

• Moderna Therapeutics, Inc. Appoints Oncology Leader Dr. Stephen Kelsey As President Of Onkaido Therapeutics

  7/1/2014

• Moderna Therapeutics, Inc. Named To CNBC Disruptor 50 List

  6/17/2014

• Booming Moderna Therapeutics, Inc. Doubles Footprint In Cambridge Due To Rapid Growth

  6/13/2014